Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-538"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-21"^^xsd:date2
dcterms:Is Part Of	lp_eu:Placing on the market and use of biocidal products (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20100921.19.2-538"2
lpv:hasSubsequent	lp_eu:2010-09-21-Speech-2-5392
lpv:speaker	lp:Catherine Soullie2
lpv:spokenAs	member; EPP (2009-07-14--2011-03-23)3 substitute; SEDE (2009-07-16--2011-03-23)3 substitute; IMCO (2010-03-25--2011-03-23)3 member; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2011-03-23)3 unknown; Union pour un Mouvement Populaire (2009-07-14--2011-03-23)3 substitute; Delegation for relations with Israel (2009-09-16--2011-03-23)3 member; ENVI (2009-07-16--2011-03-23)3 member; Delegation for relations with Belarus (2009-09-16--2011-03-23)3
lpv:translated text	"Mr President, as our rapporteur, Mrs Klaß, reminded us, biocidal products play an essential role, be it in the domestic – and hence private – sphere or in relation to public places. Biocides safeguard our hygiene and health on a daily basis. It is important that we achieve a coherent Community text. It needs to be coherent, first and foremost, with other European legislation. REACH legislation, for example, cannot and must not come into conflict with the regulation on biocides. It is important to avoid administrative and legislative red tape which strangles and suffocates our businesses. On this point, I should like to express my support for the compromise achieved by our rapporteur, Mrs Klaß, on the thorny issue of exclusion criteria and candidates for substitution. Similarly, the frame formulation approach for all biocidal products is an essential element of the regulation. It will significantly increase the efficacy of the Community authorisation system. Then, it is a Community text. The introduction of the concept of centralised authorisation in the Union, and the simplification of the procedure and the reduction in the authorisation times for certain tests relating to research and development activities, are two initial positive steps towards the harmonisation of the European market in biocidal products. Finally, we must not lose sight of our ambitions for this text: protection, of course, but the construction of our Community market and European innovation must also be an integral part of our approach."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph